Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Sumatriptan. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1D known ✓ | P28221 | 10/20 | 0.63 |
| ▸ | HTR1B known ✓ | P28222 | 9/20 | 0.63 |
| ▸ | HTR1A | P08908 | 9/20 | 0.63 |
| ▸ | HTR2A | P28223 | 4/20 | 0.63 |
| ▸ | HTR5A | P47898 | 3/20 | 0.63 |
| ▸ | HTR2B | P41595 | 2/20 | 0.63 |
| ▸ | HTR7 | P34969 | 2/20 | 0.63 |
| ▸ | HTR2C | P28335 | 2/20 | 0.63 |
| ▸ | HTR1E | P28566 | 1/20 | 0.63 |
| ▸ | HTR1F | P30939 | 1/20 | 0.63 |
| ▸ | HTR3A | P46098 | 1/20 | 0.63 |
| ▸ | SLC47A1 | Q96FL8 | 1/20 | 0.63 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.48 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.48 |
| ▸ | HTR6 | P50406 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sumatriptan SCHEMBL14186903 | 0.97 | HTR1B (0.61) | HTR1DHTR1BHTR1AHTR2AHTR5A | |
| Sumatriptan SCHEMBL14186910 | 0.96 | HTR1A (0.69) | HTR1DHTR1BHTR1AHTR2AHTR5A | |
| Sumatriptan SCHEMBL14186907 | 0.95 | HTR1A (0.71) | HTR1DHTR1BHTR1AHTR2AHTR5A | |
| Sumatriptan SCHEMBL14186977 | 0.92 | HTR1D (0.52) | HTR1DHTR1BHTR1AHTR2AHTR5A | |
| Sumatriptan SCHEMBL14186914 | 0.92 | HTR1B (0.60) | HTR1DHTR1BHTR1AHTR2AHTR5A | |
| Sumatriptan SCHEMBL14186902 | 0.91 | HTR1A (0.69) | HTR1DHTR1BHTR1AHTR2AHTR5A | |
| Sumatriptan SCHEMBL14187023 | 0.91 | HTR1D (0.53) | HTR1DHTR1BHTR1AHTR2AHTR5A | |
| Sumatriptan SCHEMBL14186916 | 0.90 | HTR1B (0.58) | HTR1DHTR1BHTR1AHTR2AHTR5A | |
| Sumatriptan SCHEMBL14186891 | 0.90 | HTR1A (0.78) | HTR1DHTR1BHTR1AHTR2AHTR5A | |
| Sumatriptan SCHEMBL14186919 | 0.89 | HTR1D (0.62) | HTR1DHTR1BHTR1AHTR2AHTR5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080103189-A1 | PREPARATION AND UTILITY OF SUBSTITUTED INDOLES | AUSPEX PHARMACEUTICALS, INC. (US) | 2008-05-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080103189-A1 | PREPARATION AND UTILITY OF SUBSTITUTED INDOLES | IDO1, TPH1, IDO2 | HTR1D 71/4885HTR1B 21/4885HTR1A 18/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.